Hormone Therapy May Elevate Breast Cancer Risk in Young Women
A NIH study found that hormone therapy types influence breast cancer risk in women under 55, with unopposed estrogen reducing risk and estrogen plus progestin increasing it, highlighting the importance of personalized treatment decisions.